Outcomes and prognostic factors for squamous-cell carcinoma of the anal canal: analysis of patients from the National Cancer Data Base.
about
Cancer and lesbian, gay, bisexual, transgender/transsexual, and queer/questioning (LGBTQ) populationsPrognostic factors for response to cisplatin-based chemotherapy in advanced cervical carcinoma: a Gynecologic Oncology Group StudyVariation in the Use of Chemoradiotherapy for Stage II and III Anal Cancer: Analysis of the National Cancer Data Base.Chemoradiation with capecitabine and mitomycin-C for stage I-III anal squamous cell carcinoma.Management of refractory metastatic anal squamous cell carcinoma following disease progression on traditional chemoradiation therapyFDG-PET metabolic response predicts outcomes in anal cancer managed with chemoradiotherapy.Early squamous cell carcinoma of the anal canal resected by endoscopic submucosal dissectionA regimen of taxol, Ifosfamide, and platinum for recurrent advanced squamous cell cancer of the anal canal.Epidermoid cancer of the anal canal.Premalignant lesions of the anal canal and squamous cell carcinoma of the anal canal.Comparison of anal cancer outcomes in public and private hospital patients treated at a single radiation oncology center.Development of cerebral metastasis after medical and surgical treatment of anal squamous cell carcinoma.Comprehensive multiplatform biomarker analysis of 199 anal squamous cell carcinomas.Chemoradiotherapy in squamous cell carcinoma of the anal canal: a single institution experience.A comparison between 5-fluorouracil/mitomycin and capecitabine/mitomycin in combination with radiation for anal cancerDisparities in receipt of radiotherapy and survival by age, sex, and race among patients with non-metastatic squamous cell carcinoma of the anusSuccessful hepatectomy for metastatic squamous cell carcinoma of the anal canal-a case reportInitial Results from the Royal College of Radiologists' UK National Audit of Anal Cancer Radiotherapy 2015.Anal cancer: current standards in care and recent changes in practice.Tumours and inflammatory lesions of the anal canal and perianal skin revisited: an update and practical approach.Chemoradiotherapy for squamous cell anal carcinoma: a review of prognostic factors.Abdominoperineal resection and perineal wound healing in recurrent, persistent, or primary anal carcinoma.Squamous cell carcinoma antigen: a potentially useful prognostic marker in squamous cell carcinoma of the anal canal and margin.Image-guided IMRT with simultaneous integrated boost as per RTOG 0529 for the treatment of anal cancer.Prognostic value of human papillomavirus in anal squamous cell carcinoma.Prognostic factors for recurrence and survival in anal cancer: generating hypotheses from the mature outcomes of the first United Kingdom Coordinating Committee on Cancer Research Anal Cancer Trial (ACT I).Tumour- and treatment-related colostomy rates following mitomycin C or cisplatin chemoradiation with or without maintenance chemotherapy in squamous cell carcinoma of the anus in the ACT II trial.Anal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.Anal canal squamous cell cancer: are surgical alternatives to chemoradiation just as effective?[Proctology for internists].PET imaging in anal canal cancer: a systematic review and meta-analysis.The prognostic value of HPV combined p16 status in patients with anal squamous cell carcinoma: a meta-analysis.Background and Current Treatment of Squamous Cell Carcinoma of the Anus.The value of apparent diffusion coefficient in the assessment of cervical cancer.KRAS and BRAF mutations in anal carcinoma.The prognostic role of hemoglobin levels in patients undergoing concurrent chemo-radiation for anal cancer.Loss of Raf kinase inhibitor protein expression is associated with human papillomavirus 16 infection in anal tumors.
P2860
Q26799512-34558572-2D57-450E-A36C-15F0773980ABQ30384730-CA03973A-380C-42B5-AA51-2581CF2E1909Q31116556-E6253BC3-324D-4ACD-B215-1FD08D80A63AQ33729819-7B2A6343-AEB6-4285-9B82-EED16D7AF04AQ33885578-3257230E-60CC-4653-AD02-FF6C3394618BQ35208087-A9B27515-1B3B-4D2D-8B4D-6B291611CD78Q35662621-B6BBD4AA-E63A-4763-A659-FDB8B1EFA27FQ35692156-91818504-0973-47EF-BD61-93FDBBE05AFEQ35850176-95E008BB-072F-41F6-A7EE-09A796405432Q35850196-8205A127-A2E1-4EB4-B45C-AF6C0385BD79Q36062623-28E52405-06A5-42D0-A62D-6D16228E0145Q36326671-EA3D1928-7D05-4F8B-BB30-0CC417E75692Q36685452-685280C3-A651-4F56-A008-F651F0018331Q36786775-0E298BB5-78EE-4EB4-982A-7718DEFA512BQ37131721-BD10E449-1A4F-49E8-9658-D154D1D8622AQ37525301-A2E23E5F-0BA6-4EB2-96C8-A6886520AFC6Q37525358-DBA35C63-831E-4514-9820-16E41409B545Q37638312-327BC819-2C0A-4FC0-94CE-B6144655B242Q38315952-EC0C9BDD-D48C-46FF-87AF-8A5F2846B6C8Q38646360-D0833293-13BF-424A-8DE0-5B352CA71027Q38793604-65A94D53-6C3D-41F3-9A3F-1154A1936B8AQ38795165-5D42102F-7F71-4A07-AE09-46C2334DA65AQ39436754-2C156B16-CA55-4D4D-8E75-CD62FD7106B9Q40063703-332879F2-A388-405F-A75A-09CBFC57F1C8Q41744134-13E1E130-6A8D-4B69-94F6-354DCDCED444Q43453891-0BBF6761-17BC-4297-8F50-7AB5CE460CD8Q44243863-5724D73E-EBD0-4C6C-9EA2-5E63CDD6FDE4Q45291707-2F50CC10-F0CB-4077-BE49-8855EBD1CE85Q47261651-6DD7CD3F-0E38-4994-A19A-D57983BED393Q50201384-504DADA7-9D87-4DDC-B9B0-71BB6AA13BA9Q50260482-40845290-047B-4E26-A5B6-C36431365088Q50322944-8D88742B-96F3-4F04-8770-CB2B4566216FQ50897271-80735BF7-FEBA-44B4-844C-2E7553E301F6Q51297188-9A383399-4346-4C84-9D7C-77BFBF4BDC50Q55071072-936948D9-9F82-4FB8-B6C0-2D32B4EDEF54Q55250545-849896BD-C2E9-43D2-BEE5-48BD40639F44Q55690226-2269E952-A52C-481D-9C2F-B2FBA8854DCD
P2860
Outcomes and prognostic factors for squamous-cell carcinoma of the anal canal: analysis of patients from the National Cancer Data Base.
description
2009 nî lūn-bûn
@nan
2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Outcomes and prognostic factor ...... the National Cancer Data Base.
@ast
Outcomes and prognostic factor ...... the National Cancer Data Base.
@en
type
label
Outcomes and prognostic factor ...... the National Cancer Data Base.
@ast
Outcomes and prognostic factor ...... the National Cancer Data Base.
@en
prefLabel
Outcomes and prognostic factor ...... the National Cancer Data Base.
@ast
Outcomes and prognostic factor ...... the National Cancer Data Base.
@en
P2093
P1476
Outcomes and prognostic factor ...... the National Cancer Data Base.
@en
P2093
Amy Halverson
Andrew K Stewart
Clifford Y Ko
Colin E Rock
David J Bentrem
Karl Y Bilimoria
P304
P356
10.1007/DCR.0B013E31819EB7F0
P577
2009-04-01T00:00:00Z